LumiraDx SARS-COV-2 & Flu A/B RNA Star Complete Test Kit
The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete multiplex assay is intended for the rapid qualitative detection and differentiation of nucleic acid from the SARS-CoV-2, Influenza A, and/or Influenza B viruses in nasopharyngeal swabs collected in 0.85 or 0.9% saline, 1X phosphate buffered saline (PBS) pH 7.4 or compatible VTM from individuals suspected of COVID-19 and/or influenza by their healthcare provider. The assay is under FDA Emergency Use Authorization for use on the Applied Biosystems QuantStudio™ 5, Applied Biosystems QuantStudio™ 7 Flex and the BioRad CFX Opus System 96 well thermocycling platforms. .
- Direct amplification within 20 minutes or less can simplify laboratory workflow and speed time to results.
- Eliminates the need for RNA purification, allowing for simple manual sample processing before sample is added to the reaction mix.
- Flexible workflows to support low- to high-throughput testingvolumes. Actionable detection of SARS-CoV-2, Influenza A, and Influenza B for timely and accurate results .